HC Wainwright & Co. Reiterates Buy on LifeMD, Maintains $10 Price Target

Benzinga Newsdesk www.benzinga.com Neutral 86.9%

Neg 0% Neu 86.9% Pos 0%

HC Wainwright & Co. analyst Yi Chen reiterates LifeMD (NASDAQ:LFMD) with a Buy and maintains $10 price target.

Comments

No comments yet. Be the first!

HC Wainwright &amp; Co. Reiterates Buy on LifeMD, Maintains $10 Price Target